TLSA
NASDAQ
$1
Tiziana Life Sciences Ltd (TLSA)
Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the UK.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9.15 (+815.00%)
Market Cap
$202M
Beta (5Y)
0.86
Price Chart
Valuation
Market Cap$202M
P/B22.09
Profitability
Total Revenue (TTM)-$3.60M
EBITDA-$18M
EPS-$0.12
Growth & Risk
Beta (5Y)0.86
Sharpe Ratio-0.19